1965
DOI: 10.1161/01.cir.32.6.936
|View full text |Cite
|
Sign up to set email alerts
|

Limitations of Hyperbaric Oxygenation in Occlusive Arterial Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

1967
1967
2020
2020

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 8 publications
0
5
0
Order By: Relevance
“…It is proposed that the underlying mechanism of HBO therapy that is predominantly involved in improving ischemic PAOD is the increase of vascular wall permeability and production of hypoxia-inducible factor (HIF)-1α and stromal cell-derived factor (SDF)-1α that enhance the angiogenesis, circulatory EPCs level and blood flow in the ischemic area [ 24 , 25 ]. Unsatisfactorily, the overall limb salvage and progression of the ischemic process have not been significantly decreased in patients receiving HBO therapy [ 26 ]. This may be due to the diffusion of oxygen into the ischemic organ that creates a hyperbaric environment being extremely limited [ 27 , 28 ] in severe PAOD patients.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is proposed that the underlying mechanism of HBO therapy that is predominantly involved in improving ischemic PAOD is the increase of vascular wall permeability and production of hypoxia-inducible factor (HIF)-1α and stromal cell-derived factor (SDF)-1α that enhance the angiogenesis, circulatory EPCs level and blood flow in the ischemic area [ 24 , 25 ]. Unsatisfactorily, the overall limb salvage and progression of the ischemic process have not been significantly decreased in patients receiving HBO therapy [ 26 ]. This may be due to the diffusion of oxygen into the ischemic organ that creates a hyperbaric environment being extremely limited [ 27 , 28 ] in severe PAOD patients.…”
Section: Introductionmentioning
confidence: 99%
“…Based on the aforementioned issues [ 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 ], we tested the hypothesis that treatment with EPCs derived from PAOD patients who received combined CD34 + cell and HBO therapy (defined as rejuvenated EPCs) would offer additional benefits than either one therapy alone for protecting limbs against the CLI procedure in nude mouse.…”
Section: Introductionmentioning
confidence: 99%
“…For these cases, additional conservative therapies such as lowdensity lipoprotein apheresis, hyperbaric oxygen therapy, or spinal cord stimulation should be adminiatered. [9][10][11][12][13][14] However, one problem with these therapies is their invasiveness. The ISDN-P therapy used in this study is noninvasive and has a high safety level, which is its most important feature.…”
Section: Discussionmentioning
confidence: 99%
“…7,8 For these patients, additional conservative therapies, such as low-density lipoprotein apheresis, hyperbaric oxygen therapy, and spinal cord stimulation were administered. 9-14 However, they were not effective in several cases. In contrast, some reports indicated that nitrate patch is useful therapy for patients with PAD.…”
mentioning
confidence: 97%
“…4 Overall, major amputation and progression of the ischemic process were not significantly decreased in CLI patients receiving HBO therapy only. 5 This may be because of diffusion of oxygen into a severely ischemic organ to create a hyperbaric environment is limited. Thus, HBO therapy may need certain conditions to result in a benefit for CLI patients, such as a certain degree of peripheral circulation.…”
Section: Introductionmentioning
confidence: 99%